Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey

In 2020, 45,364 HCT in 41,016 patients, 18,796 (41%) allogeneic and 26,568 (59%) autologous in 690 centers were reported. Changes observed were as follows: total number of HCT −6.5%, allogeneic HCT −5.1%, autologous HCT −7.5%, and were more pronounced in non-malignant disorders for allogeneic HCT an...

Descripción completa

Detalles Bibliográficos
Autores principales: Passweg, Jakob R., Baldomero, Helen, Chabannon, Christian, Corbacioglu, Selim, de la Cámara, Rafael, Dolstra, Harry, Glass, Bertram, Greco, Raffaella, Mohty, Mohamad, Neven, Bénédicte, Peffault de Latour, Régis, Perić, Zinaida, Snowden, John A., Yakoub-Agha, Ibrahim, Sureda, Anna, Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862400/
https://www.ncbi.nlm.nih.gov/pubmed/35194156
http://dx.doi.org/10.1038/s41409-022-01604-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862400/
https://www.ncbi.nlm.nih.gov/pubmed/35194156
http://dx.doi.org/10.1038/s41409-022-01604-x

Ejemplares similares